Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Intercept Pharmaceuticals (ICPT) stocks in Canada
Learn how to easily invest in Intercept Pharmaceuticals stocks.
Intercept Pharmaceuticals is a biotechnology business based in the US. Intercept Pharmaceuticals stocks (ICPT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $18.85 – a decrease of 13.23% over the previous week. Intercept Pharmaceuticals employs 498 staff and has a trailing 12-month revenue of around $354.3 million.
How to buy shares in Intercept Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ICPT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Intercept Pharmaceuticals?
- Has coronavirus impacted Intercept Pharmaceuticals shares?
- Intercept Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Intercept Pharmaceuticals stock a buy or sell?
- Intercept Pharmaceuticals performance over time
- Intercept Pharmaceuticals's financials
- How volatile are Intercept Pharmaceuticals shares?
- Does Intercept Pharmaceuticals pay a dividend?
- Other common questions
Intercept Pharmaceuticals stock price (NASDAQ:ICPT)Use our graph to track the performance of ICPT stocks over time.
Intercept Pharmaceuticals shares at a glance
|Latest market close||$15.41|
|52-week range||$11.60 - $38.94|
|50-day moving average||$16.89|
|200-day moving average||$17.45|
|Wall St. target price||$30.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.28|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Intercept Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Intercept Pharmaceuticals price performance over time
|1 week (2022-01-14)||-13.23%|
|1 month (2021-12-23)||-13.77%|
|3 months (2021-10-22)||-10.04%|
|6 months (2021-07-23)||-8.82%|
|1 year (2021-01-22)||-47.69%|
|2 years (2020-01-24)||-84.06%|
|3 years (2019-01-24)||116.45|
|5 years (2017-01-24)||105.4|
Intercept Pharmaceuticals financials
|Revenue TTM||$354.3 million|
|Gross profit TTM||$307.4 million|
|Return on assets TTM||-8.33%|
|Return on equity TTM||-143254.91%|
|Market capitalisation||$524.8 million|
TTM: trailing 12 months
Intercept Pharmaceuticals share dividends
We're not expecting Intercept Pharmaceuticals to pay a dividend over the next 12 months.
Intercept Pharmaceuticals share price volatility
Over the last 12 months, Intercept Pharmaceuticals's shares have ranged in value from as little as $11.6 up to $38.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intercept Pharmaceuticals's is 1.4075. This would suggest that Intercept Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Intercept Pharmaceuticals overview
Intercept Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid in adults. The company is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis (NASH); and other product candidates in various stages of clinical and preclinical development. It has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. The company markets its products through an internal commercial organization, a contract sales organization, and third-party distributors.
Stocks similar to Intercept Pharmaceuticals
Intercept Pharmaceuticals in the news
What to watch today: Wall Street to open lower after Nasdaq's worst week since March 2020
Stocks making the biggest moves in the premarket: Kohl's, Snap, Peloton and more
Earnings playbook: A complete guide to this week's reports, including the first of tech
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
Ask an Expert
You must be logged in to post a comment.